144 related articles for article (PubMed ID: 2853680)
1. Characterisation of insulin-like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects.
Livingston N; Pollare T; Lithell H; Arner P
Diabetologia; 1988 Dec; 31(12):871-7. PubMed ID: 2853680
[TBL] [Abstract][Full Text] [Related]
2. IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM.
Dohm GL; Elton CW; Raju MS; Mooney ND; DiMarchi R; Pories WJ; Flickinger EG; Atkinson SM; Caro JF
Diabetes; 1990 Sep; 39(9):1028-32. PubMed ID: 2166697
[TBL] [Abstract][Full Text] [Related]
3. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.
Arner P; Pollare T; Lithell H; Livingston JN
Diabetologia; 1987 Jun; 30(6):437-40. PubMed ID: 2824266
[TBL] [Abstract][Full Text] [Related]
4. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.
Handberg A; Vaag A; Vinten J; Beck-Nielsen H
Diabetologia; 1993 Jul; 36(7):668-74. PubMed ID: 8395436
[TBL] [Abstract][Full Text] [Related]
5. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
[TBL] [Abstract][Full Text] [Related]
6. A novel fetal insulin-like growth factor (IGF) I receptor. Mechanism for increased IGF I- and insulin-stimulated tyrosine kinase activity in fetal muscle.
Alexandrides TK; Smith RJ
J Biol Chem; 1989 Aug; 264(22):12922-30. PubMed ID: 2546940
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM.
Klein HH; Vestergaard H; Kotzke G; Pedersen O
Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of insulin-like growth factor I receptor by insulin receptor tyrosine kinase in intact cultured skeletal muscle cells.
Beguinot F; Smith RJ; Kahn CR; Maron R; Moses AC; White MF
Biochemistry; 1988 May; 27(9):3222-8. PubMed ID: 2839227
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I binding and receptor kinase in red and white muscle.
Zorzano A; James DE; Ruderman NB; Pilch PF
FEBS Lett; 1988 Jul; 234(2):257-62. PubMed ID: 2968920
[TBL] [Abstract][Full Text] [Related]
10. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
11. Chromaffin cells express two types of insulin-like growth factor receptors.
Danielsen A; Larsen E; Gammeltoft S
Brain Res; 1990 Jun; 518(1-2):95-100. PubMed ID: 2167752
[TBL] [Abstract][Full Text] [Related]
12. Impaired insulin-like growth factor I-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse.
Cascieri MA; Slater EE; Vicario PP; Green BG; Bayne ML; Saperstein R
Diabetologia; 1989 Jun; 32(6):342-7. PubMed ID: 2547681
[TBL] [Abstract][Full Text] [Related]
13. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
Thies RS; Molina JM; Ciaraldi TP; Freidenberg GR; Olefsky JM
Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
[TBL] [Abstract][Full Text] [Related]
14. Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle.
Alexandrides T; Moses AC; Smith RJ
Endocrinology; 1989 Feb; 124(2):1064-76. PubMed ID: 2536310
[TBL] [Abstract][Full Text] [Related]
15. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
Hotamisligil GS; Budavari A; Murray D; Spiegelman BM
J Clin Invest; 1994 Oct; 94(4):1543-9. PubMed ID: 7523453
[TBL] [Abstract][Full Text] [Related]
16. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.
Damsbo P; Vaag A; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1991 Apr; 34(4):239-45. PubMed ID: 1906024
[TBL] [Abstract][Full Text] [Related]
17. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
18. Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats.
Slieker LJ; Roberts EF; Shaw WN; Johnson WT
Diabetes; 1990 May; 39(5):619-25. PubMed ID: 2332119
[TBL] [Abstract][Full Text] [Related]
19. Effects of exercise training on the relationship between insulin binding and insulin-stimulated tyrosine kinase activity in rat skeletal muscle.
Santos RF; Mondon CE; Reaven GM; Azhar S
Metabolism; 1989 Apr; 38(4):376-86. PubMed ID: 2542721
[TBL] [Abstract][Full Text] [Related]
20. Insulin and insulin-like-growth-factor-I (IGF-I) receptors in Xenopus laevis oocytes. Comparison with insulin receptors from liver and muscle.
Hainaut P; Kowalski A; Giorgetti S; Baron V; Van Obberghen E
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):673-8. PubMed ID: 1847619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
